In Vivo CRO Market Size, Share & Trends Analysis Report By Type (Rodent, Non-Rodent), By GLP Type (Non-GLP, GLP Toxicology), By Indication (Pain Management, Oncology), By Region (North America, APAC), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
In Vivo CRO Market Growth & Trends
The global in vivo cro market size is expected to reach USD 7.92 billion by 2030, registering a CAGR of 8.2% according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.
In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to the rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.
Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor for USD 3.3 billion. The patent cliff, high research and development cost involved, and globalization in the clinical trial process has driven the
In Vivo CRO Market Report Highlights
In Vivo CRO Market Growth & Trends
The global in vivo cro market size is expected to reach USD 7.92 billion by 2030, registering a CAGR of 8.2% according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.
In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to the rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.
Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor for USD 3.3 billion. The patent cliff, high research and development cost involved, and globalization in the clinical trial process has driven the
In Vivo CRO Market Report Highlights
- Rodent-based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice are the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.
- Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and the focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects
- North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs
- Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth
- Some of the key market players include Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. GLP type
1.1.2. Type
1.1.3. Indication
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
1.9.3. Objective
1.9.4. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
CHAPTER 3. IN VIVO CRO MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Changing Regulatory Landscape
3.3.1.2. Increase In Offshoring Medical Device Manufacturing to Emerging Countries
3.3.1.3. Rising Demand for Advanced Products
3.3.1.4. Implementation Of International Standards by Contract Manufacturers
3.3.1.5. Rising Price Competition and Requirement to Reduce Cost
3.3.1.6. Increasing Complexity concerning Product Design and Engineering
3.3.2. Market restraint analysis
3.3.2.1. Compliance Issues While Outsourcing
3.3.2.2. Changing Scenarios in Developing Countries
3.3.2.3. Regulatory And Legal Compliance
3.3.2.4. Contractual Obligation
3.3.3. Penetration & Growth Prospect Mapping
3.3.4. Covid Impact Analysis
3.3.5. Major Deals and Strategic Alliances Analysis
3.3.6. Industry Analysis - Porter’s
3.3.7. Pestle Analysis
CHAPTER 4. IN VIVO CRO MARKET: TYPE SEGMENT ANALYSIS
4.1. In Vivo CRO Market: Definition & Scope
4.2. In Vivo CRO Market: Segment Dashboard
4.3. In Vivo CRO Market: Market Share Analysis, 2021 & 2030
4.3.1. Rodent Based In Vivo GLP Type
4.3.1.1. Rodent Based In Vivo GLP Type Market, 2018 - 2030 (USD Million)
4.3.2. Rats Based In Vivo CRO
4.3.2.1. Rats Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.3.3. Mice Based In Vivo CRO
4.3.3.1. Mice Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.3.4. Others
4.3.4.1. Others Market, 2018 - 2030 (USD Million)
4.4. Non-Rodent Based In Vivo GLP Type
4.4.1. Non-Rodent Based In Vivo GLP Type Market, 2018 - 2030 (USD Million)
4.4.2. Hamsters Based In Vivo CRO
4.4.2.1. Hamsters Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.4.3. Guinea Pigs Based In Vivo CRO
4.4.3.1. Guinea Pigs Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.4.4. Gerbils Based In Vivo CRO
4.4.4.1. Gerbils Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.4.5. Others Based In Vivo CRO
4.4.5.1. Others Based In Vivo CRO Market, 2018 - 2030 (USD Million)
CHAPTER 5. IN VIVO CRO MARKET: GLP TYPE SEGMENT ANALYSIS
5.1. In Vivo CRO Market: Definition & Scope
5.2. In Vivo CRO Market: Segment Dashboard
5.3. In Vivo CRO Market: Market Share Analysis, 2021 & 2030
5.4. Non GLP
5.4.1. Non GLP Market, 2018 - 2030 (USD Million)
5.4.2. In-House
5.4.2.1. In-House Market, 2018 - 2030 (USD Million)
5.4.3. Outsourcing
5.4.3.1. Outsourcing Market, 2018 - 2030 (USD Million)
5.5. GLP Toxicology
5.5.1. GLP Toxicology Market, 2018 - 2030 (USD Million)
5.5.2. In House
5.5.2.1. In-House Market, 2018 - 2030 (USD Million)
5.5.3. Outsourcing
5.5.3.1. Outsourcing Market, 2018 - 2030 (USD Million)
CHAPTER 6. IN VIVO CRO MARKET: INDICATION SEGMENT ANALYSIS
6.1. In Vivo CRO Market: Definition & Scope
6.2. In Vivo CRO Market: Segment Dashboard
6.3. In Vivo CRO Market: Market Share Analysis, 2021 & 2030
6.4. Autoimmune/Inflammatory Conditions
6.4.1. Autoimmune/Inflammatory Conditions Market, 2018 - 2030 (USD Million)
6.4.2. Rheumatoid Arthritis
6.4.2.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
6.4.3. Multiple Sclerosis
6.4.3.1. Multiple Sclerosis Market, 2018 - 2030 (USD Million)
6.4.4. Osteoarthritis
6.4.4.1. Osteoarthritis Market, 2018 - 2030 (USD Million)
6.4.5. Irritable Bowel Syndrome
6.4.5.1. Irritable Bowel Syndrome Market, 2018 - 2030 (USD Million)
6.4.6. Others
6.4.6.1. Others Market, 2018 - 2030 (USD Million)
6.5. Pain Management
6.5.1. Pain Management Market, 2018 - 2030 (USD Million)
6.5.2. Chronic Pain
6.5.2.1. Chronic Pain Market, 2018 - 2030 (USD Million)
6.5.3. Acute Pain
6.5.3.1. Acute pain Market, 2018 - 2030 (USD Million)
6.6. Oncology
6.6.1. Oncology Market, 2018 - 2030 (USD Million)
6.6.2. Blood Cancer
6.6.2.1. Blood Cancer Market, 2018 - 2030 (USD Million)
6.6.3. Solid Tumor
6.6.3.1. Solid Tumor Market, 2018 - 2030 (USD Million)
6.6.3.2. Syngeneic Model
6.6.3.2.1. Syngeneic Model Market, 2018 - 2030 (USD Million)
6.6.3.3. Patient-Derived Xenograft
6.6.3.3.1. Patient-Derived Xenograft Market, 2018 - 2030 (USD Million)
6.6.3.4. Xenograft
6.6.3.4.1. Xenograft Market, 2018 - 2030 (USD Million)
6.6.3.5. Others
6.6.3.5.1. Others Market, 2018 - 2030 (USD Million)
6.6.4. CNS Conditions
6.6.4.1. CNS Conditions Market, 2018 - 2030 (USD Million)
6.6.4.2. Epilepsy
6.6.4.2.1. Epilepsy Market, 2018 - 2030 (USD Million)
6.6.4.3. Parkinson’s Disease
6.6.4.3.1. Parkinson’s Disease, 2018 - 2030 (USD Million)
6.6.4.4. Huntington’s Disease
6.6.4.4.1. Huntington’s Disease, 2018 - 2030 (USD Million)
6.6.4.5. Stroke
6.6.4.5.1. Storke, 2018 - 2030 (USD Million)
6.6.4.6. Traumatic Brain Injury
6.6.4.6.1. Traumatic Brain Injury, 2018 - 2030 (USD Million)
6.6.4.7. ALS
6.6.4.7.1. ALS, 2018 - 2030 (USD Million)
6.6.4.8. Muscle Regeneration
6.6.4.8.1. Muscle Regeneration, 2018 - 2030 (USD Million)
6.6.4.9. Others
6.6.4.9.1. Others, 2018 - 2030 (USD Million)
6.6.5. Diabetes
6.6.5.1. Diabetes Market, 2018 - 2030 (USD Million)
6.6.6. Obesity
6.6.6.1. Obestiy Market, 2018 - 2030 (USD Million)
6.6.7. Others
6.6.7.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 7. IN VIVO CRO MARKET: REGIONAL ANALYSIS
7.1. In Vivo CRO Market: Regional market share analysis, 2021 & 2030
7.2. North America
7.2.1. North America In Vivo CRO Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. In Vivo CRO Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.2. U.K.
7.3.2.1. U.K. In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.4. Italy
7.3.4.1. Italy In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Spain In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.6. France
7.3.6.1. France In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.3. India
7.4.3.1. India In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.4. Japan
7.4.4.1. Japan In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Australia In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. South Korea In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Mexico In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Argentina In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5.5. Colombia
7.5.5.1. Colombia In Vivo CRO Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA In Vivo CRO Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa In Vivo CRO Market, 2018 - 2030 (USD Million)
7.6.3. South Arabia
7.6.3.1. South Africa In Vivo CRO Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE In Vivo CRO Market, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company Profiles
8.1.1. Quintiles
8.1.1.1. Company overview
8.1.1.2. Financial performance
8.1.1.3. Product benchmarking
8.1.1.4. Strategic initiatives
8.1.2. Charles River Laboratories
8.1.2.1. Company overview
8.1.2.2. Financial performance
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. Icon Plc
8.1.3.1. Company overview
8.1.3.2. Financial performance
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Covance Inc
8.1.4.1. Company overview
8.1.4.2. Financial performance
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. Paraxel International
8.1.5.1. Company overview
8.1.5.2. Financial performance
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. Pharmaceutical Product Development (PPD)
8.1.6.1. Company overview
8.1.6.2. Financial performance
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. Theorem Clinical Research
8.1.7.1. Company overview
8.1.7.2. Financial performance
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. InVentiv Health
8.1.8.1. Company overview
8.1.8.2. Financial performance
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Wuxi AppTec, Inc
8.1.9.1. Company overview
8.1.9.2. Financial performance
8.1.9.3. Product benchmarking
8.1.9.4. Strategic initiatives
8.1.10. AMERICAN PRECLINICAL GLP TYPE, LLC.
8.1.10.1. Company overview
8.1.10.2. Financial performance
8.1.10.3. Product benchmarking
8.1.10.4. Strategic initiatives
8.1.11. EVOTEC (US), INC.
8.1.11.1. Company overview
8.1.11.2. Financial performance
8.1.11.3. Product benchmarking
8.1.11.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. GLP type
1.1.2. Type
1.1.3. Indication
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
1.9.3. Objective
1.9.4. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
CHAPTER 3. IN VIVO CRO MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Changing Regulatory Landscape
3.3.1.2. Increase In Offshoring Medical Device Manufacturing to Emerging Countries
3.3.1.3. Rising Demand for Advanced Products
3.3.1.4. Implementation Of International Standards by Contract Manufacturers
3.3.1.5. Rising Price Competition and Requirement to Reduce Cost
3.3.1.6. Increasing Complexity concerning Product Design and Engineering
3.3.2. Market restraint analysis
3.3.2.1. Compliance Issues While Outsourcing
3.3.2.2. Changing Scenarios in Developing Countries
3.3.2.3. Regulatory And Legal Compliance
3.3.2.4. Contractual Obligation
3.3.3. Penetration & Growth Prospect Mapping
3.3.4. Covid Impact Analysis
3.3.5. Major Deals and Strategic Alliances Analysis
3.3.6. Industry Analysis - Porter’s
3.3.7. Pestle Analysis
CHAPTER 4. IN VIVO CRO MARKET: TYPE SEGMENT ANALYSIS
4.1. In Vivo CRO Market: Definition & Scope
4.2. In Vivo CRO Market: Segment Dashboard
4.3. In Vivo CRO Market: Market Share Analysis, 2021 & 2030
4.3.1. Rodent Based In Vivo GLP Type
4.3.1.1. Rodent Based In Vivo GLP Type Market, 2018 - 2030 (USD Million)
4.3.2. Rats Based In Vivo CRO
4.3.2.1. Rats Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.3.3. Mice Based In Vivo CRO
4.3.3.1. Mice Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.3.4. Others
4.3.4.1. Others Market, 2018 - 2030 (USD Million)
4.4. Non-Rodent Based In Vivo GLP Type
4.4.1. Non-Rodent Based In Vivo GLP Type Market, 2018 - 2030 (USD Million)
4.4.2. Hamsters Based In Vivo CRO
4.4.2.1. Hamsters Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.4.3. Guinea Pigs Based In Vivo CRO
4.4.3.1. Guinea Pigs Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.4.4. Gerbils Based In Vivo CRO
4.4.4.1. Gerbils Based In Vivo CRO Market, 2018 - 2030 (USD Million)
4.4.5. Others Based In Vivo CRO
4.4.5.1. Others Based In Vivo CRO Market, 2018 - 2030 (USD Million)
CHAPTER 5. IN VIVO CRO MARKET: GLP TYPE SEGMENT ANALYSIS
5.1. In Vivo CRO Market: Definition & Scope
5.2. In Vivo CRO Market: Segment Dashboard
5.3. In Vivo CRO Market: Market Share Analysis, 2021 & 2030
5.4. Non GLP
5.4.1. Non GLP Market, 2018 - 2030 (USD Million)
5.4.2. In-House
5.4.2.1. In-House Market, 2018 - 2030 (USD Million)
5.4.3. Outsourcing
5.4.3.1. Outsourcing Market, 2018 - 2030 (USD Million)
5.5. GLP Toxicology
5.5.1. GLP Toxicology Market, 2018 - 2030 (USD Million)
5.5.2. In House
5.5.2.1. In-House Market, 2018 - 2030 (USD Million)
5.5.3. Outsourcing
5.5.3.1. Outsourcing Market, 2018 - 2030 (USD Million)
CHAPTER 6. IN VIVO CRO MARKET: INDICATION SEGMENT ANALYSIS
6.1. In Vivo CRO Market: Definition & Scope
6.2. In Vivo CRO Market: Segment Dashboard
6.3. In Vivo CRO Market: Market Share Analysis, 2021 & 2030
6.4. Autoimmune/Inflammatory Conditions
6.4.1. Autoimmune/Inflammatory Conditions Market, 2018 - 2030 (USD Million)
6.4.2. Rheumatoid Arthritis
6.4.2.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
6.4.3. Multiple Sclerosis
6.4.3.1. Multiple Sclerosis Market, 2018 - 2030 (USD Million)
6.4.4. Osteoarthritis
6.4.4.1. Osteoarthritis Market, 2018 - 2030 (USD Million)
6.4.5. Irritable Bowel Syndrome
6.4.5.1. Irritable Bowel Syndrome Market, 2018 - 2030 (USD Million)
6.4.6. Others
6.4.6.1. Others Market, 2018 - 2030 (USD Million)
6.5. Pain Management
6.5.1. Pain Management Market, 2018 - 2030 (USD Million)
6.5.2. Chronic Pain
6.5.2.1. Chronic Pain Market, 2018 - 2030 (USD Million)
6.5.3. Acute Pain
6.5.3.1. Acute pain Market, 2018 - 2030 (USD Million)
6.6. Oncology
6.6.1. Oncology Market, 2018 - 2030 (USD Million)
6.6.2. Blood Cancer
6.6.2.1. Blood Cancer Market, 2018 - 2030 (USD Million)
6.6.3. Solid Tumor
6.6.3.1. Solid Tumor Market, 2018 - 2030 (USD Million)
6.6.3.2. Syngeneic Model
6.6.3.2.1. Syngeneic Model Market, 2018 - 2030 (USD Million)
6.6.3.3. Patient-Derived Xenograft
6.6.3.3.1. Patient-Derived Xenograft Market, 2018 - 2030 (USD Million)
6.6.3.4. Xenograft
6.6.3.4.1. Xenograft Market, 2018 - 2030 (USD Million)
6.6.3.5. Others
6.6.3.5.1. Others Market, 2018 - 2030 (USD Million)
6.6.4. CNS Conditions
6.6.4.1. CNS Conditions Market, 2018 - 2030 (USD Million)
6.6.4.2. Epilepsy
6.6.4.2.1. Epilepsy Market, 2018 - 2030 (USD Million)
6.6.4.3. Parkinson’s Disease
6.6.4.3.1. Parkinson’s Disease, 2018 - 2030 (USD Million)
6.6.4.4. Huntington’s Disease
6.6.4.4.1. Huntington’s Disease, 2018 - 2030 (USD Million)
6.6.4.5. Stroke
6.6.4.5.1. Storke, 2018 - 2030 (USD Million)
6.6.4.6. Traumatic Brain Injury
6.6.4.6.1. Traumatic Brain Injury, 2018 - 2030 (USD Million)
6.6.4.7. ALS
6.6.4.7.1. ALS, 2018 - 2030 (USD Million)
6.6.4.8. Muscle Regeneration
6.6.4.8.1. Muscle Regeneration, 2018 - 2030 (USD Million)
6.6.4.9. Others
6.6.4.9.1. Others, 2018 - 2030 (USD Million)
6.6.5. Diabetes
6.6.5.1. Diabetes Market, 2018 - 2030 (USD Million)
6.6.6. Obesity
6.6.6.1. Obestiy Market, 2018 - 2030 (USD Million)
6.6.7. Others
6.6.7.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 7. IN VIVO CRO MARKET: REGIONAL ANALYSIS
7.1. In Vivo CRO Market: Regional market share analysis, 2021 & 2030
7.2. North America
7.2.1. North America In Vivo CRO Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. In Vivo CRO Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.2. U.K.
7.3.2.1. U.K. In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.4. Italy
7.3.4.1. Italy In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Spain In Vivo CRO Market, 2018 - 2030 (USD Million)
7.3.6. France
7.3.6.1. France In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.3. India
7.4.3.1. India In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.4. Japan
7.4.4.1. Japan In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Australia In Vivo CRO Market, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. South Korea In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Mexico In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Argentina In Vivo CRO Market, 2018 - 2030 (USD Million)
7.5.5. Colombia
7.5.5.1. Colombia In Vivo CRO Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA In Vivo CRO Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa In Vivo CRO Market, 2018 - 2030 (USD Million)
7.6.3. South Arabia
7.6.3.1. South Africa In Vivo CRO Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE In Vivo CRO Market, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company Profiles
8.1.1. Quintiles
8.1.1.1. Company overview
8.1.1.2. Financial performance
8.1.1.3. Product benchmarking
8.1.1.4. Strategic initiatives
8.1.2. Charles River Laboratories
8.1.2.1. Company overview
8.1.2.2. Financial performance
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. Icon Plc
8.1.3.1. Company overview
8.1.3.2. Financial performance
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Covance Inc
8.1.4.1. Company overview
8.1.4.2. Financial performance
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. Paraxel International
8.1.5.1. Company overview
8.1.5.2. Financial performance
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. Pharmaceutical Product Development (PPD)
8.1.6.1. Company overview
8.1.6.2. Financial performance
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. Theorem Clinical Research
8.1.7.1. Company overview
8.1.7.2. Financial performance
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. InVentiv Health
8.1.8.1. Company overview
8.1.8.2. Financial performance
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Wuxi AppTec, Inc
8.1.9.1. Company overview
8.1.9.2. Financial performance
8.1.9.3. Product benchmarking
8.1.9.4. Strategic initiatives
8.1.10. AMERICAN PRECLINICAL GLP TYPE, LLC.
8.1.10.1. Company overview
8.1.10.2. Financial performance
8.1.10.3. Product benchmarking
8.1.10.4. Strategic initiatives
8.1.11. EVOTEC (US), INC.
8.1.11.1. Company overview
8.1.11.2. Financial performance
8.1.11.3. Product benchmarking
8.1.11.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Secondary sources
Table 2 List of Abbreviations
Table 3 Global In Vivo CRO market, by region, 2018 - 2030 (USD Million)
Table 4 Global In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 5 Global In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 6 Global In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 7 North America In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 8 North America In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 9 North America In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 10 North America In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 11 U.S. In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 12 U.S. In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 13 U.S. In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 14 Canada In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 15 Canada In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 16 Canada In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 17 Europe In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 18 Europe In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 19 Europe In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 20 Europe In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 21 Germany In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 22 Germany In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 23 Germany In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 24 France In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 25 France In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 26 France In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 27 Italy In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 28 Italy In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 29 Italy In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 30 U.K. In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 31 U.K. In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 32 U.K. In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 33 Spain In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 34 Spain In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 35 Spain In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 36 Asia Pacific In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 37 Asia Pacific In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 38 Asia Pacific In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 39 Asia Pacific In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 40 Japan In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 41 Japan In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 42 Japan In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 43 China In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 44 China In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 45 China In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 46 India In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 47 India In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 48 India In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 49 Australia In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 50 Australia In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 51 Australia In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 52 South Korea In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 53 South Korea In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 54 South Korea In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 55 Latin America In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 56 Latin America In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 57 Latin America In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 58 Latin America In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 59 Brazil In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 60 Brazil In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 61 Brazil In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 62 Mexico In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 63 Mexico In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 64 Mexico In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 65 Argentina In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 66 Argentina In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 67 Argentina In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 68 Colombia In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 69 Colombia In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 70 Colombia In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 71 MEA In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 72 MEA In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 73 MEA In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 74 MEA In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 75 South Africa In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 76 South Africa In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 77 South Africa In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 78 South Arabia In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 79 South Arabia In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 80 South Arabia In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 81 UAE In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 82 UAE In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 83 UAE In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 1 List of Secondary sources
Table 2 List of Abbreviations
Table 3 Global In Vivo CRO market, by region, 2018 - 2030 (USD Million)
Table 4 Global In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 5 Global In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 6 Global In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 7 North America In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 8 North America In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 9 North America In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 10 North America In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 11 U.S. In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 12 U.S. In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 13 U.S. In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 14 Canada In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 15 Canada In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 16 Canada In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 17 Europe In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 18 Europe In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 19 Europe In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 20 Europe In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 21 Germany In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 22 Germany In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 23 Germany In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 24 France In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 25 France In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 26 France In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 27 Italy In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 28 Italy In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 29 Italy In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 30 U.K. In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 31 U.K. In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 32 U.K. In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 33 Spain In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 34 Spain In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 35 Spain In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 36 Asia Pacific In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 37 Asia Pacific In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 38 Asia Pacific In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 39 Asia Pacific In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 40 Japan In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 41 Japan In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 42 Japan In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 43 China In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 44 China In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 45 China In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 46 India In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 47 India In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 48 India In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 49 Australia In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 50 Australia In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 51 Australia In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 52 South Korea In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 53 South Korea In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 54 South Korea In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 55 Latin America In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 56 Latin America In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 57 Latin America In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 58 Latin America In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 59 Brazil In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 60 Brazil In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 61 Brazil In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 62 Mexico In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 63 Mexico In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 64 Mexico In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 65 Argentina In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 66 Argentina In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 67 Argentina In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 68 Colombia In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 69 Colombia In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 70 Colombia In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 71 MEA In Vivo CRO market, by country, 2018 - 2030 (USD Million)
Table 72 MEA In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 73 MEA In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 74 MEA In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 75 South Africa In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 76 South Africa In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 77 South Africa In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 78 South Arabia In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 79 South Arabia In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 80 South Arabia In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
Table 81 UAE In Vivo CRO market, by GLP type, 2018 - 2030 (USD Million)
Table 82 UAE In Vivo CRO market, by type, 2018 - 2030 (USD Million)
Table 83 UAE In Vivo CRO market, by indication, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 In Vivo CRO market snapshot (2021)
Fig. 6 In Vivo CRO market segmentation
Fig. 7 Parent market outlook
Fig. 8 Related/ancillary market outlook
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Porter’s five forces analysis
Fig. 13 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 14 In Vivo CRO Market outlook: Segment dashboard
Fig. 15 In Vivo CRO Market: type movement analysis
Fig. 16 Rodent type market, 2018 - 2030 (USD Million)
Fig. 17 non-Rodent type market, 2018 - 2030 (USD Million)
Fig. 18 In Vivo CRO market: GLP Type movement analysis
Fig. 19 non-GLP market, 2018 - 2030 (USD Million)
Fig. 20 GLP toxicology market, 2018 - 2030 (USD Million)
Fig. 21 In Vivo CRO market: Indication movement analysis
Fig. 22 Autoimmune market, 2018 - 2030 (USD Million)
Fig. 23 Pain management market, 2018 - 2030 (USD Million)
Fig. 24 Oncology market, 2018 - 2030 (USD Million)
Fig. 25 CNS conditions market, 2018 - 2030 (USD Million)
Fig. 26 Diabetes market, 2018 - 2030 (USD Million)
Fig. 26 Obesity market, 2018 - 2030 (USD Million)
Fig. 26 Others market, 2018 - 2030 (USD Million)
Fig. 24 Global In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 25 North America In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 26 U.S. In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 27 Canada In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 28 Europe In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 29 U.K. In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 30 Germany In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 31 France In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 32 Italy In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 33 Spain In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 34 Asia Pacific In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 35 Japan In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 36 China In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 37 India In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 38 South Korea In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 39 Latin America In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 40 Brazil In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 41 Mexico In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 42 Argentina In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 43 Colombia In Vivo CRO market, 2018 - 2030 (USD Million
Fig. 44 Middle East & Africa In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 45 South Africa In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 46 Saudi Arabia In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 47 UAE In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 In Vivo CRO market snapshot (2021)
Fig. 6 In Vivo CRO market segmentation
Fig. 7 Parent market outlook
Fig. 8 Related/ancillary market outlook
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Porter’s five forces analysis
Fig. 13 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 14 In Vivo CRO Market outlook: Segment dashboard
Fig. 15 In Vivo CRO Market: type movement analysis
Fig. 16 Rodent type market, 2018 - 2030 (USD Million)
Fig. 17 non-Rodent type market, 2018 - 2030 (USD Million)
Fig. 18 In Vivo CRO market: GLP Type movement analysis
Fig. 19 non-GLP market, 2018 - 2030 (USD Million)
Fig. 20 GLP toxicology market, 2018 - 2030 (USD Million)
Fig. 21 In Vivo CRO market: Indication movement analysis
Fig. 22 Autoimmune market, 2018 - 2030 (USD Million)
Fig. 23 Pain management market, 2018 - 2030 (USD Million)
Fig. 24 Oncology market, 2018 - 2030 (USD Million)
Fig. 25 CNS conditions market, 2018 - 2030 (USD Million)
Fig. 26 Diabetes market, 2018 - 2030 (USD Million)
Fig. 26 Obesity market, 2018 - 2030 (USD Million)
Fig. 26 Others market, 2018 - 2030 (USD Million)
Fig. 24 Global In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 25 North America In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 26 U.S. In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 27 Canada In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 28 Europe In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 29 U.K. In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 30 Germany In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 31 France In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 32 Italy In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 33 Spain In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 34 Asia Pacific In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 35 Japan In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 36 China In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 37 India In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 38 South Korea In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 39 Latin America In Vivo CRO Market, 2018 - 2030 (USD Million)
Fig. 40 Brazil In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 41 Mexico In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 42 Argentina In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 43 Colombia In Vivo CRO market, 2018 - 2030 (USD Million
Fig. 44 Middle East & Africa In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 45 South Africa In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 46 Saudi Arabia In Vivo CRO market, 2018 - 2030 (USD Million)
Fig. 47 UAE In Vivo CRO market, 2018 - 2030 (USD Million)
